Bicara Therapeutics Inc.
BCAX
$14.81
$0.271.86%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -5.96% | 155.46% | 0.00% | -11.54% | -- |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1,596.03% | -65.98% | 0.00% | 316.89% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -3.64% | 153.07% | 0.00% | -10.82% | -- |
|
|||||
Total Current Assets | -3.64% | 153.07% | 0.00% | -10.82% | -- |
Net Property, Plant & Equipment | 55.33% | -12.12% | 0.00% | -24.05% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 212.91% | 1.29% | 0.00% | -0.29% | -- |
Total Assets | -2.70% | 151.06% | 0.00% | -10.77% | -- |
|
|||||
Total Accounts Payable | 129.77% | -58.10% | 0.00% | 46.99% | -- |
Total Accrued Expenses | 5.44% | 10.18% | 0.00% | -4.57% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 97.08% | 2.67% | 0.00% | 5.26% | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 24.23% | -9.87% | 0.00% | 6.50% | -- |
|
|||||
Total Current Liabilities | 24.23% | -9.87% | 0.00% | 6.50% | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -4.38% | -36.87% | 0.00% | -41.67% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 23.96% | -10.23% | 0.00% | 5.23% | -- |
|
|||||
Common Stock & APIC | 0.46% | 8,995.28% | 0.00% | 83.49% | -- |
Retained Earnings | -10.48% | -9.57% | 0.00% | -19.32% | -- |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -3.47% | 391.55% | 0.00% | -17.48% | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 0.00% | 0.00% | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 0.00% | 0.00% | -- |
|
|||||
Total Common Equity | -3.47% | 391.55% | 0.00% | -17.48% | -- |
Total Preferred Equity | -- | -- | 0.00% | 0.00% | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.47% | 164.70% | 0.00% | -11.90% | -- |
|